Home › Compare › EAPH vs QYLD

EAPH vs QYLD: Dividend Comparison 2026

EAPH yields 20000000.00% · QYLD yields 12.24%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EAPH wins by $4.875981653489057e+49M in total portfolio value
10 years
EAPH
EAPH
● Live price
20000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875981653489057e+49M
Annual income
$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full EAPH calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
12.24%
Share price
$16.70
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$6,038.84
Full QYLD calculator →

Portfolio growth — EAPH vs QYLD

📍 EAPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEAPHQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EAPH + QYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EAPH pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EAPH
Annual income on $10K today (after 15% tax)
$1,700,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,040.82/yr
After 10yr DRIP, annual income (after tax)
$5,133.01/yr
At 15% tax rate, EAPH beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EAPH + QYLD for your $10,000?

EAPH: 50%QYLD: 50%
100% QYLD50/50100% EAPH
Portfolio after 10yr
$2.4379908267445285e+49M
Annual income
$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EAPH right now

EAPH
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-5.1
Piotroski
3/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EAPH buys
0
QYLD buys
0
No recent congressional trades found for EAPH or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEAPHQYLD
Forward yield20000000.00% ✓12.24%
Annual dividend / share$2.00$2.04 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.875981653489057e+49M$26.5K ✓
Annual income after 10y$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓$6,038.84
Total dividends collected$4.875978515990276e+49M$28.5K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: EAPH vs QYLD ($10,000, DRIP)

YearEAPH PortfolioEAPH Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$2,000,010,700$2,000,000,000.00$10,384$1,224.49+$2000.00M → EAPH
2$373,835,915,712,384$373,833,775,700,934.50$10,900$1,388.18+$373835915.70M → EAPH
3$65,304,953,364,964,970,000$65,304,553,360,535,160,000.00$11,576$1,590.76+$65304953364964.96M → EAPH
4$10,661,728,832,755,500,000,000,000$10,661,658,956,455,399,000,000,000.00$12,447$1,844.20+$10661728832755499008.00M → EAPH
5$1,626,767,783,781,495,000,000,000,000,000$1,626,756,375,731,643,800,000,000,000,000.00$13,567$2,164.97+$1.626767783781495e+24M → EAPH
6$231,974,330,054,625,100,000,000,000,000,000,000$231,972,589,413,096,470,000,000,000,000,000,000.00$15,003$2,576.05+$2.319743300546251e+29M → EAPH
7$30,915,106,403,922,057,000,000,000,000,000,000,000,000$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00$16,853$3,110.04+$3.0915106403922057e+34M → EAPH
8$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00$19,251$3,813.85+$3.8505079858392777e+39M → EAPH
9$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00$22,390$4,756.08+$4.4821026103531426e+44M → EAPH
10$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00$26,548$6,038.84+$4.875981653489057e+49M → EAPH

EAPH vs QYLD: Complete Analysis 2026

EAPH — Stock

Parallel Industries Inc. does not have significant operations. Previously, the company was involved in development and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. It focuses on development, licenses, production, and markets prescription and over-the-counter products. The company was formerly known as Easton Pharmaceuticals Inc. and changed its name to Parallel Industries Inc. in December 2020. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada.

Full EAPH Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this EAPH vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EAPH vs SCHDEAPH vs JEPIEAPH vs OEAPH vs KOEAPH vs MAINEAPH vs XYLDEAPH vs JEPQEAPH vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.